Antifungals: mechanism of action and resistance, established and novel drugs.
about
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.Crystal structure of cytochrome P450 14 -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitorsTrypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen HitAntifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug actionExperimental and conformational analyses of interactions between butenafine and lipidsPd@Ag Nanosheets in Combination with Amphotericin B Exert a Potent Anti-Cryptococcal Fungicidal EffectIdentification of essential genes in the human fungal pathogen Aspergillus fumigatus by transposon mutagenesis.Antifungal activity of Ag(I) and Zn(II) complexes of aminobenzolamide (5-sulfanilylamido-1,3,4-thiadiazole-2-sulfonamide) derivatives.Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect.Discovery of Short Peptides Exhibiting High Potency against Cryptococcus neoformansDivergence in fitness and evolution of drug resistance in experimental populations of Candida albicansMonoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosisAntifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthase.Didehydroroflamycoin pentaene macrolide family from Streptomyces durmitorensis MS405(T) : production optimization and antimicrobial activity.Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.Impact of fluconazole prophylaxis on cortisol levels in critically ill surgical patientsDesign, synthesis, and antifungal activities of novel triazole derivatives containing the benzyl group.(E)-N-[3-(Imidazol-1-yl)-1-phenyl-propyl-idene]hydroxyl-amine.Miconazole: a historical perspective.Comparison of superficial mycosis treatment using Butenafine and Bifonazole nitrate clinical efficacyThe Aspergillus fumigatus Damage Resistance Protein Family Coordinately Regulates Ergosterol Biosynthesis and Azole Susceptibility.Molecular aspects of azoles-induced teratogenesis.Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity.In vitro Antifungal Susceptibility Patterns of Candida Albicans from HIV and AIDS Patients Attending the Nylon Health District Hospital in Douala, Cameroon.Triazole derivatives with improved in vitro antifungal activity over azole drugsHas the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics.Human and ecological risk assessment of a crop protection chemical: a case study with the azole fungicide epoxiconazole.Active site mapping and substrate channeling in the sterol methyltransferase pathway.Nonclinical toxicological evaluation of occidiofungin, a unique glycolipopeptide antifungal.Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.Quantitative analysis of the relative transcript levels of ABC transporter Atr genes in Aspergillus nidulans by real-time reverse transcription-PCR assayIn vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.Inhibition of oxidative metabolism of tocopherols with omega-N-heterocyclic derivatives of vitamin E.Antifungal drug testing by combining minimal inhibitory concentration testing with target identification by gas chromatography-mass spectrometry.Effect of clotrimazole on the pump cycle of the Na,K-ATPase.Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.In Vitro Anti-Malassezia Activity of Castanea crenata Shell and Oil-Soluble Glycyrrhiza ExtractsIn vitro activity and in vivo efficacy of icofungipen (PLD-118), a novel oral antifungal agent, against the pathogenic yeast Candida albicans.
P2860
Q24813721-4FB794AF-F0FA-4699-B24C-087649B6226FQ27630604-3B33E482-9355-4058-8877-7AFF75235743Q27653636-2171A23B-1C22-469C-AA67-EB1A162B59E6Q28343624-D5B42ABC-F55D-4D73-A3E0-997A3207DD5AQ28364108-D14F2C47-07E3-406F-BEBD-BB50A0AB415EQ28550084-31AC9DA7-61D4-4797-972C-9D1961C1C15DQ30913384-CC629B2D-786C-43CE-8775-BAAADF9C4910Q31805168-642466FD-5250-43C9-B4A0-F4503AA195BCQ31936121-D3BEF8DE-7E61-4A0D-9A60-8AAF252BD846Q33532335-89671BD9-D5F1-4BD5-A3BB-C9B7AB1C8A49Q33636123-9045917C-DA29-4EC6-B5E9-3E533B0816CBQ33996119-95DCA1C4-3758-4B76-9FB8-730C5F0232D2Q34045440-011AE4F8-C525-43E9-9C2C-6028116182D8Q34075010-6A3C4019-3FD0-4233-AB54-B06FCD9ED87FQ34363747-1A8CCEF4-0C0F-47F6-9853-846248668138Q34722281-D6E5A59C-7925-4DA5-AA7C-3A1AD1A385CBQ34768569-574A75F6-520F-4490-8515-E064ED8FFE89Q35125400-2335FDEA-92C8-4F95-B38C-C7ADD2E49D22Q35184974-45B4408A-6814-4934-9C69-B28ADE73F781Q35808030-DAC31197-BD48-4E7D-8735-007A966FD714Q36441479-E019C53D-30CD-4E45-A519-C9D9E0A6A7AEQ36648276-A36537F1-B0DF-4779-A367-C68DF2911258Q36687065-B45E828A-78F9-494A-9600-63B189AFE94CQ37681552-11B88B0A-09FE-4B08-969E-839251536AC9Q37684378-15CF1D87-DDBF-4476-AE27-1FFFD2943CDCQ37693048-63482C49-1C8D-4841-ACC2-83AC3C6B34CDQ37701941-A4C7D74F-458E-4BB7-96A8-D9EE90ED46F0Q37904672-5EABAC34-5A5A-4325-83F8-1957F5E44592Q38165985-EF8DC36C-A9B3-4133-81E2-A29A562332D9Q38363534-C30C43AE-62A7-4081-9EB7-FD52D3C3EFC5Q39332767-36BC72A3-F2FD-4803-94C0-D98877F70AF2Q39477082-595A3791-1F98-4974-A108-CCE95C97C366Q39639247-BBF94458-C04D-439C-8A99-2F62E356F7FFQ39954754-42A9833F-3EF6-4FF6-8B71-883E93335E85Q39957277-BC3C3C96-B4F2-4995-89DE-68AD8222D4DDQ40262172-26B54C2A-C175-4C8C-9314-74EF029BE78AQ40897001-C65FDEAC-1162-4645-972D-502678DEFE89Q41816687-DF8A21D8-EF19-4AFA-8181-5CCF7F344FB7Q42037361-0F7E22B1-FB6D-4C8B-8F13-1925AD893FC0Q43152151-9D71028D-1A77-4ED6-9FFD-4D34CD23828F
P2860
Antifungals: mechanism of action and resistance, established and novel drugs.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Antifungals: mechanism of action and resistance, established and novel drugs.
@ast
Antifungals: mechanism of action and resistance, established and novel drugs.
@en
Antifungals: mechanism of action and resistance, established and novel drugs.
@nl
type
label
Antifungals: mechanism of action and resistance, established and novel drugs.
@ast
Antifungals: mechanism of action and resistance, established and novel drugs.
@en
Antifungals: mechanism of action and resistance, established and novel drugs.
@nl
prefLabel
Antifungals: mechanism of action and resistance, established and novel drugs.
@ast
Antifungals: mechanism of action and resistance, established and novel drugs.
@en
Antifungals: mechanism of action and resistance, established and novel drugs.
@nl
P1476
Antifungals: mechanism of action and resistance, established and novel drugs.
@en
P2093
Georgopapadakou NH
P304
P356
10.1016/S1369-5274(98)80087-8
P577
1998-10-01T00:00:00Z